Side chain unsaturated 1.alpha.-hydroxyvitanim D homologs

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

552653, A61K 3159, C07J17200, C07J17500

Patent

active

052505235

ABSTRACT:
This invention provides novel vitamin D-related compounds characterized by extended unsaturated side chain structures. Such compounds exhibit increased activity in arresting the proliferation and promoting the differentiation of malignant cells with only minimal calcemic activity and thus represents new therapeutic agents applicable and uniquely useful in differentiation therapy of malignant diseases. The activity characteristics of these compounds provide the basis of a method for the treatment of neoplastic diseases, specifically leukemoid diseases.

REFERENCES:
patent: 4391802 (1983-04-01), Suda et al.
patent: 4689180 (1987-08-01), DeLuca et al.
patent: 4717721 (1988-05-01), DeLuca et al.
patent: 4851401 (1989-07-01), DeLuca et al.
patent: 4927815 (1990-05-01), DeLuca et al.
CA 113: 78822r, Calverley et al.
Perlman et al., Biochemistry, 29(1), pp. 190-196 (1990).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Side chain unsaturated 1.alpha.-hydroxyvitanim D homologs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Side chain unsaturated 1.alpha.-hydroxyvitanim D homologs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Side chain unsaturated 1.alpha.-hydroxyvitanim D homologs will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1003909

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.